Quotes 5-day view Delayed Nasdaq
01/14/2021
01/15/2021
01/19/2021
01/20/2021
01/21/2021
Date
115.91(c)
120.16(c)
123.9(c)
123.38(c)
121.305 Last
876 887
1 051 250
744 416
1 085 177
321 970 Volume
+2.32% +3.67% +3.11% -0.42% -1.68% Change
Sales 2020
385 M - -
Net income 2020
-204 M - -
Net cash position 2020
510 M - -
P/E ratio 2020
-48,6x
Yield 2020
-
Sales 2021
463 M - -
Net income 2021
-194 M - -
Net cash position 2021
408 M - -
P/E ratio 2021
-52,1x
Yield 2021
-
Capitalization
10 533 M 10 533 M -
EV / Sales 2020
26,0x
EV / Sales 2021
21,9x
Nbr of Employees
1 039
Free-Float
95,4%
Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's...
Notations Surperformance© of Natera, Inc.
Trading Rating : Investor Rating :
All news about NATERA, INC.
News in other languages on NATERA, INC.
- No features available -
Analyst Recommendations on NATERA, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends NATERA, INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
9
Average target price
118,11 $
Last Close Price
123,38 $
Spread / Highest target
13,5%
Spread / Average Target
-4,27%
Spread / Lowest Target
-29,5%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
